Skip to content

Neuroimaging in Acute Stroke

Predictive Value of Brainomix Software CT Evaluation for Final Outcome in Patients With Acute Non-lacunar Stroke

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05864495
Acronym
e-Stroke
Enrollment
500
Registered
2023-05-18
Start date
2023-05-01
Completion date
2025-05-31
Last updated
2023-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke, Acute, Stroke, Ischemic

Keywords

stroke, neuroimaging, e-ASPECTS, Brainomix

Brief summary

The main aim of this study is to identify the predictive value of CT parameters (e-ASPECTS, CTP, collateral vessel status, volume, and location of ischemic lesion volume) at a 3-month functional outcome defined by the modified Rankin scale (mRS) in patients with non-lacunar stroke after recanalization treatment (Intravenous Thrombolytic Therapy and/or Mechanical Thrombectomy, or conservative treatment).

Detailed description

This is a multicenter observational study of patients with acute ischemic non-lacunar stroke and premorbid mRS ≤ 4, who are treated with intravenous thrombolysis and/or endovascular thrombectomy (EVT) or conservatively in stroke centers that are part of the National Stroke Research Network (STROCZECH). All patients with suspected acute stroke routinely undergo baseline non-contrast computer tomography (NCCT) and single-phase CT-angiography (CTA) from the aortic arch to the vertex. Follow-up neuroimaging includes NCCT (a standard of care in the Czech Republic) up to 36 hours after endovascular therapy (EVT) or intravenous thrombolysis (IVT) treatment. The optimal timing of follow-up imaging \> 24 hours is chosen since it represents the earliest time point for accurate delineation of acute ischemia volume. NCCT will be performed on a multi-detector spiral 64 series CT machine. The NCCT examination is followed by CTA using 50-100 ml of iodine conjugate (Visipaque, GE Healthcare, Piscataway, NJ, USA), which is administered at a rate of 4 ml/s. The range of CTA is from the aortic arch to the distal intracranial artery. The width of the basic CT sections for further reconstruction is 0.75 mm. Automated processing of NCCT, CTA, and CT perfusion (CTP) will be performed using the latest CE-marked version of e-Stroke software (Brainomix, Oxford, UK) at baseline, and follow-up imaging will be processed using algorithms in development by Brainomix. The e-Stroke image processing algorithms follow an artificial intelligence (AI) approach with a combination of traditional 3D graphics and statistical methods, and machine learning classification techniques. The algorithms have been trained on a large dataset (\> 10000 images) containing a wide range of real-world CT scans from stroke patients and negative controls with ground-truth data from additional imaging data such as MRI acquired within 1-2 hours of the CT scan, along with other modalities and clinical information. This dataset contains examples of CT scans captured with scanners from all major manufacturers, from a wide range of countries worldwide. Within e-Stroke NCCT, CTA and CTP will be processed using e-ASPECTS, e-CTA, and e-CTP modules respectively. It must be noted that e-Stroke is intended to be used as a decision support tool. Results are designed to be interpreted in the clinical context and radiological interpretation of the user. Standardly acquired non-contrast CT, CTA, and CTP will be processed. Within this project, imaging data from the e-STROKE system and clinical data stored in the RES-Q registry (REgistry of Stroke Care Quality) will be fused and subsequently analyzed. The RES-Q registry collects information related to hospital care for stroke patients, especially in the acute phase. Since 2021, the Ministry of Health of the Czech Republic has included RES-Q in the national policy as one of the indicators of stroke care. Therefore, the range of parameters assessed within this project will provide unique and potentially new information related to stroke that could impact the provision of non-hospital care in the future.

Interventions

None listed

Sponsors

St. Anne's University Hospital Brno, Czech Republic
CollaboratorOTHER
Na Homolce Hospital
CollaboratorOTHER
General University Hospital, Prague
CollaboratorOTHER
Pardubice Hospital
CollaboratorUNKNOWN
University Hospital Hradec Kralove
CollaboratorOTHER
University Hospital, Motol
CollaboratorOTHER
University Hospital Kralovske Vinohrady
CollaboratorUNKNOWN
Hospital Pisek
CollaboratorUNKNOWN
Vitkovice Hospital
CollaboratorOTHER
České Budějovice Hospital
CollaboratorOTHER
Jihlava Hospital
CollaboratorUNKNOWN
Brno University Hospital
CollaboratorOTHER
Karvina Miners Hospital
CollaboratorUNKNOWN
Regional Hospital Liberec
CollaboratorOTHER
Vyskov Hospital
CollaboratorUNKNOWN
Thomayer University Hospital
CollaboratorOTHER
Municipal Hospital Ostrava
CollaboratorOTHER
Regional Hospital Mlada Boleslav
CollaboratorUNKNOWN
Regional Hospital Pribram
CollaboratorUNKNOWN
University Hospital Ostrava
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Acute ischemic stroke within 12 hours of onset, treated with intravenous thrombolysis and/or mechanical thrombectomy or conservatively. * Unknown time of onset of ischemic stroke. * Wake-up stroke (with symptoms of stroke since awakening).

Exclusion criteria

* Pre-event modified Rankin Scale (mRS) score \> 4 points. * Acute haemorrhagia or other NCCT finding excluding dg. ischemic stroke.

Design outcomes

Primary

MeasureTime frameDescription
Modified Rankin Scale3 monthsTo find the predictive value of CT parameters (e-ASPECTS, CTP (CTP provides absolute and relative information about brain perfusion parameters, namely cerebral blood flow (CBF), cerebral blood volume (CBV), mean transit time (MTT), and time to peak (TTP). MTT is the time between the arterial inflow and the venous outflow), collateral vessel status, volume and location of ischemic lesion volume) at a 3 month functional outcome defined by the modified Rankin scale (mRS) in patients with non-lacunar stroke after recanalization treatment (IVT and/or MT, or conservative therapy)

Countries

Czechia

Contacts

Primary ContactJiří Hynčica
jiri.hyncica@fno.cz0042059737

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026